In this work, to further define the precise mechanisms underlying epigenetic modulation of anti-tumor immunity in the tumor microenvironment, we generate a conditional deletion model to disable DNMT1 activity, specifically in the endothelium. This evidence concerns the gene DNMT1 and neoplasm.